Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Ramos, Edwin
Risk Factors for Adverse Outcomes in Patients Hospitalized With Lower Gastrointestinal Bleeding.
The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study.
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy. Cancer Treat Rev. 2017 Apr; 55:181-189.
View in:
PubMed
subject areas
Aminopyridines
Antineoplastic Agents
Carbazoles
Carcinoma, Non-Small-Cell Lung
Humans
Lactams
Lactams, Macrocyclic
Lung Neoplasms
Organophosphorus Compounds
Piperidines
Pyrazoles
Pyrimidines
Receptor Protein-Tyrosine Kinases
Sulfones
authors with profiles
Ravi Salgia